Sort   by:  
 Page size 
UnknownGender differences in microRNA expression in levodopa-naive PD patients.
Not available
S-EPMC10267004 | biostudies-literature
UnknownSex-Independent Upregulation of miR-146a-5p in Parkinson's Disease Patients: A Longitudinal Study.
Not available
S-EPMC12610492 | biostudies-literature
UnknownGender Is the Main Predictor of Wearing-Off and Dyskinesia in Levodopa-Naive Patients with Parkinson's Disease.
Not available
S-EPMC12625146 | biostudies-literature
UnknownEffects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocol.
Not available
S-EPMC2903576 | biostudies-literature
UnknownClinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism.
Not available
S-EPMC6058265 | biostudies-literature
UnknownThe Economic Burden of Insulin Injection-Induced Lipohypertophy. Role of Education: The ISTERP-3 Study.
Not available
S-EPMC9056437 | biostudies-literature
UnknownAssociation Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism.
Not available
S-EPMC8649245 | biostudies-literature
UnknownNatural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry.
Not available
S-EPMC6688272 | biostudies-literature
UnknownEnoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study.
Not available
S-EPMC9164243 | biostudies-literature
UnknownSymptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation.
Not available
S-EPMC7845079 | biostudies-literature
Sort   by:  
 Page size